Zobrazeno 1 - 10
of 1 282
pro vyhledávání: '"R, Naccarato"'
Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease
Autor:
R. Naccarato, Romilda Cardin, Fabio Farinati, Michelangelo Fiorentino, W. F. Grigioni, Antonietta D'Errico, Attilio Cecchetto
Publikováno v:
Journal of Viral Hepatitis. 8:34-40
An imbalance between cytoproliferation and apoptosis may be relevant in liver carcinogenesis. The aim of this study was to analyse these parameters in patients with chronic liver damage in relation to the aetiology of the disease. Forty-eight patient
Autor:
Silvia Bacchetti, C. Venturi, Fabio Farinati, F. Marino, R. Scalerta, Mario Lise, Marina Bortolami, Luciano Giacomelli, A. Floreani, R. Naccarato
Publikováno v:
Digestive and Liver Disease. 34:794-801
Background . Kupffer cells, monocytes and infiltrating T cells have been considered the major source of interleukin-1β and tumour necrosis factor-alpha in the liver. Aims . To explore the expression of interleukin-1β and tumour necrosis factor-alph
Autor:
R. Naccarato, Donato Nitti, Paolo Carraro, Massimo Rugge, M. PIebani, Fabio Farinati, Romilda Cardin, László Herszényi, M. De Paoli, Giovanni Roveroni, W.F. Grigioni, A. D'Errico
Publikováno v:
Carcinogenesis. 17:2581-2587
Background: Cysteine proteases [cathepsin B (CATB),cathepsin L (CATL)], the serine protease urokinase-typeplasminogen activator (UPA) and its inhibitor type-1(PAI-1) play an important part in cancer invasion. No dataare available on the relationship
Autor:
C. Venturi, Marina Bortolami, Maria Chiaramonte, R. Naccarato, A. Floreani, Paolo Fabris, F. De Lazzari
Publikováno v:
European Journal of Gastroenterology & Hepatology. 6:625-628
Objective: To investigate the behaviour of serum tumour necrosis factor-alpha (TNF-alpha) during alpha-interferon (alpha-IFN) treatment in patients with chronic viral hepatitis. Design: The study included 31 patients with chronic active hepatitis: fi
Aspartic proteinases and gastrin in the diagnosis of gastric cancer and gastric precancerous changes
Autor:
M Deboni, Mario Plebani, Flavio Valiante, R. Naccarato, F. Dimario, R. Cielo, Fabio Farinati, M. C. Fanton, G Della Libera, Alessandro P. Burlina
Publikováno v:
European Journal of Gastroenterology & Hepatology. 5:707-712
Objective: Gastric cancer patients have been reported to have low pepsinogen I (PGA), increased pepsinogen II (PGC) levels and a reduced PGA/PGA ratio. We tested PGA, PGC and gastrin (G) levels, and the PGA/PGC ratio to verify the usefulness of these
Autor:
C. Surrenti, F. Orlandi, R. Naccarato, Federico Manenti, M. Podda, Luigi Pagliaro, F.B. Bianchi, Pier Maria Battezzati
Publikováno v:
Journal of Hepatology. 17:332-338
The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to humans, has been suggested for treatment of primary biliary cirrhosis to improve cholestasis and reduce hepatocellular damage. Efficacy of treatment has been studi
Autor:
C. S. Goodwin, B. Worsley, E. Pillai, V. Willems, H. D. Janisch, H. Langmaack, P. Sanchez, M. Alcalde, A. Lancho, P. Carpintero, R. Garcia, J. M. Pajares, P. Ya. Grigoriev, V. A. Isakov, E. P. Iakovenko, A. V. Iakovenko, K. Vogt, H. Hahn, I. H. Rehmann, M. Hedding-Eckerich, J. Blessing, G. M. Sobala, D. A. F. Lynch, B. Gallacher, M. F. Dixon, A. T. R. Axon, E. Bayerdörffer, G. Mannes, A. Sommer, W. Höchter, J. Weingart, R. Hatz, S. Miehlke, N. Lehn, G. Ruckdeschel, P. Dirschedl, M. Stolte, R. J. Adamek, M. Wegener, S. Birkholz, W. Opferkuch, G. H. Rühl, B. Wedmann, J. Labenz, E. Gyenes, G. H. R’hl, G. Börsch, R. Maieron, C. Rizzi, L. Zoratti, S. Andreoli, G. L. Da Broi, C. A. Beltrami, Zhuya Chengyl, Mou Yangiong, Hua Jiesong, Zhang Zhenhua, L. Bierti, E. G. Bolis, R. Di Battista, R. de Franchis, D. J. McAvinchey, M. Laurence, J. O’Riordan, M. Fantazi, M. Khawaja, E Bologna, M. Stroppiana, S. Peyre, R. Pulitano’, C. Sategna-Guidetti, E. Martin, T. Alarcön, J. C. Sanz, M. I. Jimonez, M. López-Brea, A. Burette, Y. Glupczynski, C. Deprez, F. Di Mario, M. Ferrana, G. Battaglia, P. Dotto, F. Vianello, G. A. Grasso, R. Fiocca, L. Villiani, O. Luinetti, A. Gianatti, R. Boldorini, M. Lazzaroni, G. Bianchi Porro, E. Trespi, M. Perego, C. Alvisi, B. Cesana, E. Solcia, R. P. H. Logan, R. R. Greaves, P. A. Gummett, M. M. Walker, Q. N. Karim, A. E. Duggan, J. H. Baron, J. J. Misiewicz, J. Lohmarm, L. H. H. Porst, J. Schönlebe, H. Riedel, F. Catalano, G. Rizzo, M. T. Ayoubi Khajekini, G. Branciforte, G. Inserra, A. Liberti, R. Suriani, C. Pallante, M. Ravizza, D. Mazzucco, D. Galliano, M. Malandrino, R. Oneglio, M. Colozza, E. Gaia, F. Sallio, D. Colozza, C. Grandis, G. B. Forte, M. E. Bottiglieri, R. Durasco, E. Grimaldi, P. Rocco, H. X. Xia, M. A. Daw, S. Sant, S. Beattie, C. T. Keane, C. A. O’Morain, H. Larsson, M. L. Berglund, P. Tessaro, R. Schiavon, M. G. Contini, T. Ton, L. Norberto, M. Cassaro, M. Rugge, M. Guido, R. Baffa, S. Gloriosa, F. Turatello, R. Naccarato, R. Collins, C. O’Moram, T. P. Kemmer, J. E. Dominguez-Munoz, H. Klingel, P. Malfertheiner, C. J. McCarthy, M. McDermott, D. Hourihane, C. O’Morain, M. T. Droy-Lefiax, B. Forestier, D. Guillomain, O. Plique, D. Brugmann, F. Mégraud, H. Lamouliatte, P. H. Bernard, R. Cayla, M. Mégraud, A. de Mascarel, A. Quintonl, A. McLaren, S. R. McDowell, A. A. McColm, C. O’Malley, J. Bagshaw, F. Bouffant, P. Marelli, L. Cellini, M. Campa, B. Dainelli, G. Soldani, M. del Tacca, G. Ferrini, G. Larcinese, N. Semperlotti, Gy. Molnar, A. Fzentmihalyi, A. Takats, G. Gero, J. Penyige, Gy. Mark, J. Martínez-Gómez, D. García-Novo, D. Acuña-Quinõs, M. Gimeno, S. Vigneri, R. Termini, A. Scialabba, G. Pisciotta, R. Gusmaroli, F. Milesi, P. Mule, M. Menegatti, C. Reale, J. Holten, D. Vaira
Publikováno v:
Irish Journal of Medical Science. 161:88-100